Search Results 881-890 of 1789 for 批改网ai写作,ai写作的网文,ai画图的网址,下载ai 的网站,ai音乐生成网址,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat
The purpose of this study is to determine the maximum tolerated dose of this drug (MEDI-551) in subjects with advanced B-cell malignancies. Expansion to occur ...
About this study. Laboratory studies suggest that the study drug may stop cancer cells from growing by affecting an interaction between proteins in the ...
About this study. RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune system in different ways and stop cancer cells from growing.
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of NB003 in subjects with Advanced Solid Tumors. Participation eligibility.
About this study. Phase 1b of the study will evaluate the safety of talimogene laherparepvec in combination with ipilimumab. Phase 2 is a randomized study ...
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
About this study. A pilot to test feasibility of improving patient/caretaker quality of life and resilience. Participation eligibility.
Through his Metabolic Basis for Type 2 Diabetes and Aging Research Lab at Mayo Clinic, Dr. Nair works with other researchers investigating metabolism, ...
About this study. The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.